Clearwater Analytics Holdings, Inc. discloses regulatory information on its investment management technology business, operating results, and capital structure. Its Form 8-K filings document quarterly financial results, non-GAAP reconciliations, material-event disclosures, material agreements, and capital-structure updates tied to the company’s cloud-native platform model.
Clearwater’s proxy and related filings cover shareholder voting matters, governance disclosures, board and compensation items, risk factors, and formal records for corporate actions. The filing record also reflects disclosure areas relevant to a public software company serving institutional investors, including recurring revenue metrics, debt and equity matters, and shareholder approval processes.
Clearwater Analytics (CWAN) has a Form 144 notice for the potential sale of 11,275 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $217,043.75. The filing shows that Clearwater Analytics had 288,154,032 shares outstanding of common stock at the time referenced.
The securities to be sold come from an exercise of stock options for 6,275 shares on 11/17/2025, paid in cash, and from 5,000 restricted stock units acquired on 01/01/2024. The notice also lists recent sales over the past three months under a Rule 10b5-1 sales plan and direct sales by the same insider.
Clearwater Analytics (CWAN) Chief Technology Officer Souvik Das reported two open-market sales of Class A common stock on 11/12/2025 via Form 4. He sold 10,000 shares at a weighted average price of $20.1194 and another 10,000 shares at $20.30, executed under a Rule 10b5-1 trading plan adopted on May 5, 2025.
Following these transactions, Das beneficially owned 106,066 shares. The filing notes the first transaction included multiple trades between $20.06 and $20.30.
Clearwater Analytics (CWAN) insider activity: Chief Technology Officer Souvik Das reported RSU vesting and related sales on 09/30/2025. He acquired 5,156 and 4,688 shares of Class A common stock at $0.00 upon RSU settlement, then sold 2,537 and 2,790 shares at $17.6772 to cover tax withholding under a mandated “sell to cover.”
Following these transactions, directly held shares were 126,066. Derivative holdings reported included RSUs with 42,187 and 67,031 units remaining. The filing is an amendment made solely to correct the total number of derivative securities beneficially owned; it does not change the previously reported transactions.
Clearwater Analytics (CWAN): Form 144 filed for a planned sale. A holder gave notice to sell 20,000 common shares with an aggregate market value of $368,000, expected around 11/12/2025 on the NYSE via Morgan Stanley Smith Barney. The shares to be sold were acquired as restricted stock units on 02/28/2024. Recent activity shows sales over the past 3 months: 5,327 shares for $94,166.44 on 09/30/2025, 10,000 shares for $205,750.00 on 09/08/2025, and 10,000 shares for $200,000.00 on 08/20/2025. Shares outstanding were 288,154,032.
Clearwater Analytics Holdings, Inc. (CWAN): Wellington Management Group LLP and affiliated entities filed a Schedule 13G reporting beneficial ownership of 17,793,701 shares of CWAN common stock, representing 6.18% of the class as of the reported date.
The Wellington group reports shared voting power over 14,131,341 shares and shared dispositive power over 17,793,701 shares, with no sole voting or dispositive power. Wellington Management Company LLP separately reports shared voting power over 13,573,535 shares and shared dispositive power over 14,716,525 shares, with its stake noted at 5.1%. The filing is made on a passive basis and states the securities were acquired and are held in the ordinary course of business.
Clearwater Analytics (CWAN) reported Q3 2025 results. Revenue rose to $205.1M from $115.8M a year ago as recent acquisitions contributed, with gross profit of $134.5M and operating income of $6.6M. Higher interest and amortization drove a net loss of $10.5M. Year-to-date revenue reached $513.9M.
The company completed the acquisitions of Enfusion and Beacon, recording goodwill of $1.27B and intangible assets of $714.1M at quarter end. Operating cash flow was $120.6M for the nine months, while investing cash outflows of $988.5M reflected deal activity. CWAN entered a 2025 Credit Agreement with $800M term loans and a $200M revolver; the net carrying amount of notes payable was $838.9M. Cash and equivalents were $60.8M. As of November 3, 2025, shares outstanding were 288,154,032 Class A and 4,506,422 Class B; Class C and D were converted and retired on June 12, 2025.
Clearwater Analytics (CWAN) reported Q3 2025 results. Revenue rose to $205.1M from $115.8M a year ago as recent acquisitions contributed, with gross profit of $134.5M and operating income of $6.6M. Higher interest and amortization drove a net loss of $10.5M. Year-to-date revenue reached $513.9M.
The company completed the acquisitions of Enfusion and Beacon, recording goodwill of $1.27B and intangible assets of $714.1M at quarter end. Operating cash flow was $120.6M for the nine months, while investing cash outflows of $988.5M reflected deal activity. CWAN entered a 2025 Credit Agreement with $800M term loans and a $200M revolver; the net carrying amount of notes payable was $838.9M. Cash and equivalents were $60.8M. As of November 3, 2025, shares outstanding were 288,154,032 Class A and 4,506,422 Class B; Class C and D were converted and retired on June 12, 2025.
Clearwater Analytics (CWAN) furnished an update announcing its financial results for the third quarter ended September 30, 2025. The company issued a press release and referenced its earnings call. The update includes non‑GAAP measures with reconciliations to the most comparable GAAP metrics provided in the press release. The information is furnished under Item 2.02 and is not deemed filed under Section 18.
Clearwater Analytics (CWAN) furnished an update announcing its financial results for the third quarter ended September 30, 2025. The company issued a press release and referenced its earnings call. The update includes non‑GAAP measures with reconciliations to the most comparable GAAP metrics provided in the press release. The information is furnished under Item 2.02 and is not deemed filed under Section 18.
Clearwater Analytics (CWAN) CFO Jim Cox reported insider trades on 10/15/2025. He exercised 16,898 stock options at $4.40, then sold 6,275 shares at $17.92 and 5,000 shares at a $18.0459 weighted average. The filing also shows 10,623 shares withheld to cover taxes, a sale mandated by the company. These transactions were made under a Rule 10b5‑1 trading plan adopted on March 11, 2024.
Following the activity, his directly held Class A shares stood at 338,983, and he reported 271,633 derivative securities (options) remaining. One sale included multiple trades between $17.96 and $18.17.
Clearwater Analytics (CWAN): Form 144 notice of proposed sale
A stockholder filed a Form 144 indicating an intent to sell 11,275 shares of CWAN common stock with an aggregate market value of $201,822.50. The filing lists Morgan Stanley Smith Barney LLC as broker and NYSE as the exchange, with an approximate sale date of 10/15/2025. Shares outstanding are shown as 287,938,740.
The shares to be sold include 6,275 acquired on 10/15/2025 via stock option exercise (cash) and 5,000 acquired on 01/01/2023 via restricted stock units. Recent activity shows sales by James Cox: 5,919 shares on 09/30/2025 for $104,631.35 and 11,275 shares on 09/15/2025 for $219,937.25 and on 08/15/2025 for $218,906.53, each under a 10b5-1 plan.
Insider transactions by Scott Erickson, Chief Revenue Officer of Clearwater Analytics (CWAN). On 09/30/2025 Mr. Erickson had restricted stock units (RSUs) vest and settle into Class A common stock: 3,125 shares from one grant and 5,156 shares from a second grant. Concurrently, he sold 2,805 and 1,700 shares on the same date to satisfy tax withholding under the issuer's mandatory "sell to cover" policy. After these transactions, Mr. Erickson directly beneficially owned 19,552 Class A shares. The RSUs have scheduled quarterly vesting (6.25% every three months) and settlement schedules extending through 2034 and 2035 for the two grants.